Global Suprapubic Catheter Market, by Indication (Benign Prostate Hyperplasia, Urinary Incontinence, and Others), by Material (Rubber, Plastic, and Polyvinyl Chloride), by End User (Hospitals, Ambulatory Surgical Centers, Urology Surgical Centers, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) is estimated to be valued at US$ 15,392.75 Million in 2022 and is expected to exhibit a CAGR of 7.3% during the forecast period (2022-2030), as highlighted in a new report published by Coherent Market Insights.
Increasing demand for suprapubic catheters, owing to rising prevalence of bladder cancer is expected to be a major factor driving the suprapubic catheter market over the forecast period. For instance, according to American Cancer Society, around 80,470 new cases of bladder cancer were expected in the U.S. in 2019. Among these, estimated cases of bladder cancer in men were 61,700 and 18,770 cases of bladder cancer in women.
Global Suprapubic Catheter Market– Impact of Coronavirus (COVID-19) Pandemic
The COVID-19 pandemic and lockdowns in various countries across the globe have impacted the financial status of businesses across all sectors, including the private healthcare sector. The COVID-19 pandemic has impacted the entire supply chain of the healthcare industry, mainly due to strict lockdown in several regions. Private healthcare is one such sector that has been impacted significantly by the COVID-19 pandemic.
However, the COVID-19 pandemic had a negative impact on the global suprapubic catheter market, owing to disruption in supply chain of raw materials and decrease in the research and development activities carried out for suprapubic catheters. For instance, in July 2020, according to the data published by the National Center for Biotechnology Information, the worldwide supply chain continues to be affected by challenges relating to the COVID-19 pandemic, including delays and disruption. In some areas, it brought to light previously unseen vulnerabilities, and of course, several organizations had suffered staff shortages and losses due to COVID-19 during manufacturing of suprapubic catheters. The government of different countries imposed lockdown which restricted the import and export across the world. The coronavirus (COVID-19) pandemic has impacted health systems worldwide. There is a continuing need for clinicians to adapt practice to facilitate timely provision of medical care, whilst minimising horizontal transmission. Guidance and recommendations are increasingly available, and this rapid review aimed to provide a timely evidence synthesis on the current recommendations surrounding urogynaecological care. Due to the high number of appointments of COVID-19 patients, the normal health system has lost its ordinal functioning. COVID-19 brought a heavy burden on all health systems especially in the first wave of outbreak. Therefore, face-to-face outpatient and nonurgent activities have been postponed in many hospitals.